Key facts
as of Oct 2026- Developer of a reimbursement software designed to automate and streamline the operations of skilled nursing operators.
- MedaSync is valued at approximately $11.2M as of Oct 2026, set at its later-stage round, Aug 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $3.6M across 2 recorded rounds; the latest was Seed Round ($1.6M) in Feb 2024.
- Notable investors include Interstate Fusion Ventures, Aztec Capital, Innovation Fund America, Omega Healthcare Investors, Valley Growth Ventures — 6 tracked in total.
- MedaSync has filed 2 Form Ds with the SEC since 2018, most recently Aug 2025 ($1.6M sold to 18 investors).
- Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence$11.2M
Valued at $11.2M at its later-stage round, Aug 2025. Nothing has traded since.
Free account
More of MedaSync with a free account
- ·Watch MedaSync: the Monday email on marks, rounds and moves
Create free account
No card required
Funding rounds
2 roundsAbout MedaSync
Developer of a reimbursement software designed to automate and streamline the operations of skilled nursing operators. The company's software helps in revenue optimization, controlling costs and evaluating historical and real-time data to identify trends and support decision-making, enabling healthcare businesses to provide quality care while maintaining profitability.
- Sector
- Healthcare
- HQ
- Cleveland, OH, United States
- Founded
- 2016
- Employees
- 7
- Website
- medasync.com/
- Ownership
- Privately Held (backing)